A study of pediatric brain tumors and their association with epilepsy and anticonvulsant use

Neuroepidemiology

Volumn 16, Issue 5, 1997, Pages 248-255

  Gumey, J G ^a   Mueller, B A ^b   Preston Martin, S ^c   Mc Daniel, A M ^d   Holly, E A ^e   Pogoda, J M ^g   Davis, R L ^f  

^a SAINT LOUIS UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e Department of Epidemiology and Biostatistics ^*  (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Statology   (United States)

Author keywords

Anticonvulsants; Brain neoplasms; Children; Epidemiology; Epilepsy; Phenobarbital

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; PHENOBARBITAL;

ARTICLE; BRAIN TUMOR; CASE CONTROL STUDY; CHILD; CHILDHOOD; CONTROLLED STUDY; DRUG USE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; UNITED STATES;

EID: 0030774406     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109694     Document Type: Article

References (28)

1. Sjors K. Blennow G, Lantz G: Seizures as the presenting symptom of brain tumors in children. Acta Pae-diatr 1993;82:66-70.
2. Aicardi J: Epilepsy in Children. New York, Raven Press, 1986, p 280.
3. Gold E, Gordis L, Tonascia J, Szklo M: Increased risk of brain tumors in children exposed to barbiturates. J Natl Cancer Inst 1978.61:1031-1034.
4. Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL: Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 1996;5:599-605.
5. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Ancr TG: Epi Info, version 6. Atlanta, Centers for Disease Control and Prevention, 1995.
6. EGRET Reference Manual, revision 4. Seattle, Statistics and Epidemiology Research Corporation, 1994.
7. Gilíes FH, Sobel E. Levitón A, Hed-Icy-Whyle ET, Tavarc CJ, Adelman LS, Sobel RA: Epidemiology of seizures in children with brain tumors. J Neuro-Oncology 1992;12:53-68.
8. Clemmcnsen J, Fuglsang-Frederik-sen V, Plum CM: Are anti-convul-sants oncogenic? Lancet 1974;Vol i: 705-707.
9. Clemmcscn J, Hjalgrim-Jcnscn S: Is phénobarbital carcinogenic? A follow-up of 8078 epileptics. Ecotoxi-col Environ Saf 1978;5:457-470.
10. Annegers JF, Kurland LT, Hauser WA: Brain tumors in children exposed to barbiturates (letter). J Natl Cancer Inst 1979;63:3.
11. Gold E, Gordis L. Tonascia J, Szklo M: Brain tumors in children exposed to barbiturates (response). J Natl Cancer Inst 1979;63:3-4.
12. White SJ. McLean AEM. Howland C: Anticonvulsant drugs and cancer: A cohort study in patients with severe epilepsy. Lancet 1979;Vol i:458-460.
13. Clemmesen J, Hjalgrim-Jcnsen S: Brain tumors in children exposed to barbiturates (letter). J Natl Cancer Inst 1981;66:215.
14. Clemmesen J. Hjalgrim-Jenscn S: Does phénobarbital cause intracranial tumors? A follow-up through 35 years. Ecotoxicol Environ Saf 1981: 5:255-260.
15. Olsen JH, Boice JD, Jensen JPA, Fraumeni JF: Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 1989; 81:803-808.
16. Goldhaber MK, Selby JV, Hiatt RA, Quesenberry CP: Exposure to barbiturates in utero and during childhood and risk of intracranial and spinal cord tumors. Cancer Res 1990;50:4600-4603.
17. Olsen JH, Schulgen G. Boice JD, Whysner J, Travis LB. Williams GM. Johnson FB, McGee JO: An-ticpileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 1995:55: 294-297.
18. Prcston-Martin S, Yu MC, Benton B, Henderson BE: N-Nitroso compounds and childhood brain tumors: A case-control study. Cancer Res 1982;42:5240-5245.
19. Booker HE: Phénobarbital: Relation of plasma concentration to seizure control; in Woodbury DM, Penry JK, Pippcnger CE (eds): Antiepilcp-tic Drugs. New York. Raven Press, 1982. pp 341-350.
20. Peraino C, Fry’ RJM, Staffeldt E, Ki-siclcski WE: Effects of varying the exposure to phénobarbital on its enhancement of 2-acetylaminofluo-rene-induccd hepatic tumorigenesis in the rat. Cancer Res 1973:33: 2701-2705.
21. Peraino C. Staffeldt EF, Haugen DA, Lombard LS, Stevens FJ, Fry RJM: Effects of varying the dietary concentration of phénobarbital on its enhancement of 2-acetyIamino-fluorene-induccd hepatic tumorigenesis. Cancer Res 1980:40:3268-3273.
22. Barbason H, Rassenfosse C, Betz EH: Promotion mechanism of phénobarbital and partial hepatectomy in DENA hcpatocarcinogcnesis cell kinetics effect. Br J Cancer 1983;47: 517-525.
23. Makino T, Obara T. Ura H, Kinu-gasa T. Kobayashi H. Takahashi S. Konishi Y: Effects of phénobarbital and secondary bile acids on liver, gallbladder, and pancreas, carcinogenesis initiated by n-nitrosobis(2-hydroxypropyl)amine in hamsters. J Natl Cancer Inst 1986;76:967-975.
24. Bursh W, Lauer B. Timmcrmann-Trosiencr I. Barthel G, Schupplcr J. Schulte-Hermann R: Controlled death (apoptosis) of normal and putative prcneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984;5:453-458.
25. Schultc-Hcrmann R, Timmermann-Trosiener I, Barthel G, Bursch W: DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phénobarbital promotion. Cancer Res 1990:50:5127-5135.
26. Bursch W, Oberhammer F. Schulte-Hermann R: Cell death by apoptosis and its protective role against disease. TiPS 1992;13:245-251.
27. Kuijten RR, Bunin GR: Risk factors for childhood brain tumors. Cancer Epidemiol Biomarkers Prcv 1993;2: 277-288.
28. Shirts SB. Annegers JF, Hauser WA. Kurland LT: Cancer incidence in a cohort of patients with seizure disorders. J Natl Cancer Inst 1986:77:83-87.